ID   GM07492 iPSC GRIN2B RD
AC   CVCL_E4CN
SY   GM07492 iPSC GRIN2B Reduced Dosage
RX   PubMed=29937144;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B; Note=1 of 2 alleles.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CL ! GM07492 iPSC
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=29937144; DOI=10.1016/j.stemcr.2018.05.018; PMCID=PMC6067152;
RA   Bell S., Maussion G., Jefri M., Peng H.-S., Theroux J.-F., Silveira H.B.,
RA   Soubannier V., Wu H.-R., Hu P., Galat E., Torres-Platas S.G.,
RA   Boudreau-Pinsonneault C., O'Leary L.A., Galat V., Turecki G.,
RA   Durcan T.M., Fon E.A., Mechawar N., Ernst C.;
RT   "Disruption of GRIN2B impairs differentiation in human neurons.";
RL   Stem Cell Reports 11:183-196(2018).
//